UBS Maintains Neutral on UiPath, Lowers Price Target to $14

Benzinga Newsdesk www.benzinga.com Negative 54.8%

Neg 54.8% Neu 0% Pos 0%

UBS analyst Radi Sultan maintains UiPath (NYSE:PATH) with a Neutral and lowers the price target from $15 to $14.

Comments

No comments yet. Be the first!